-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA approves DAYBUE STIX (trofinetide), powder formulation

ASX·12/14/2025 22:07:00

The content of this announcement was automatically generated by machine and is for reference only. The original announcement can be viewed by clicking on the link below.